DK3581180T3 - Antimikrobielle sammensætninger med brusemidler - Google Patents
Antimikrobielle sammensætninger med brusemidler Download PDFInfo
- Publication number
- DK3581180T3 DK3581180T3 DK19165084.5T DK19165084T DK3581180T3 DK 3581180 T3 DK3581180 T3 DK 3581180T3 DK 19165084 T DK19165084 T DK 19165084T DK 3581180 T3 DK3581180 T3 DK 3581180T3
- Authority
- DK
- Denmark
- Prior art keywords
- antimicrobial compositions
- effervescent agents
- effervescent
- agents
- antimicrobial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462014786P | 2014-06-20 | 2014-06-20 | |
EP15810507.2A EP3157510B1 (en) | 2014-06-20 | 2015-06-19 | Antimicrobial compositions with effervescent agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3581180T3 true DK3581180T3 (da) | 2021-11-08 |
Family
ID=54868661
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15810507.2T DK3157510T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
DK19165084.5T DK3581180T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15810507.2T DK3157510T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
Country Status (31)
Country | Link |
---|---|
US (2) | US20150366857A1 (da) |
EP (3) | EP3919057A1 (da) |
JP (2) | JP6995479B2 (da) |
CN (2) | CN106572982B9 (da) |
AR (1) | AR100920A1 (da) |
AU (3) | AU2015276954B2 (da) |
BR (1) | BR112016029761B1 (da) |
CA (1) | CA2952950C (da) |
CL (2) | CL2016003273A1 (da) |
CR (2) | CR20200565A (da) |
CY (2) | CY1121995T1 (da) |
DK (2) | DK3157510T3 (da) |
EA (1) | EA034152B1 (da) |
EC (1) | ECSP16095540A (da) |
ES (2) | ES2732865T3 (da) |
HR (2) | HRP20211685T1 (da) |
HU (2) | HUE044764T2 (da) |
IL (1) | IL249622A0 (da) |
LT (2) | LT3581180T (da) |
MX (2) | MX368940B (da) |
PE (2) | PE20170304A1 (da) |
PH (1) | PH12016502548A1 (da) |
PL (2) | PL3157510T3 (da) |
PT (2) | PT3157510T (da) |
RS (2) | RS62538B1 (da) |
SI (2) | SI3581180T1 (da) |
SV (1) | SV2016005349A (da) |
TR (1) | TR201909417T4 (da) |
TW (2) | TWI732337B (da) |
UY (1) | UY36184A (da) |
WO (1) | WO2015196027A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022240897A1 (en) * | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194617A (en) * | 1988-12-17 | 1993-03-16 | Meiji Seika Kaisha, Ltd. | 2,3-disubstituted-4-hydroxyquinoline derivatives |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
DE69628466T2 (de) | 1995-09-22 | 2004-04-01 | Wakunaga Pharmaceutical Co., Ltd. | Zwischenverbindungen zur Herstellung von neunen Pyridoncarbonsäurederivate oder deren Salzen |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
AU758324B2 (en) | 1998-09-14 | 2003-03-20 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
US6187317B1 (en) * | 1999-07-14 | 2001-02-13 | Judith Taylor | Natural anti-diarrheal composition and method |
US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
JP2005097116A (ja) | 1999-11-11 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法 |
WO2003101431A1 (en) * | 2002-06-04 | 2003-12-11 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
MX2007001134A (es) | 2004-07-30 | 2007-04-17 | Abbott Lab | Preparacion de antibacterianos de acido piridonacarboxilico. |
PL3056492T3 (pl) * | 2004-10-08 | 2022-03-21 | Abbvie Inc. | Sól megluminowa i jej krystaliczne postaci leku (delafloksacyna) |
SI2377557T1 (sl) * | 2004-11-24 | 2017-02-28 | Meda Pharmaceuticals Inc. | Sestavki, ki obsegajo azelastin, in postopki njihove uporabe |
WO2006110815A1 (en) | 2005-04-11 | 2006-10-19 | Abbott Laboratories | Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
EP1745775B1 (en) | 2005-07-19 | 2008-05-28 | Ethypharm | Gastroretentive formulations and manufacturing process thereof. |
US7611739B2 (en) | 2006-01-06 | 2009-11-03 | Amerilab Technologies, Inc. | Method of using guava extract and composition including guava extract |
US7736485B2 (en) * | 2006-08-11 | 2010-06-15 | Aqua Resources Corporation | Nanoplatelet magnesium hydroxides and methods of preparing same |
CN1943561A (zh) * | 2006-08-23 | 2007-04-11 | 北京阜康仁生物制药科技有限公司 | 普卢利沙星口腔崩解片及其制备方法 |
NZ598728A (en) | 2006-12-22 | 2013-09-27 | Ironwood Pharmaceuticals Inc | Compositions comprising bile acid sequestrants for treating esophageal disorders |
AU2008258596B2 (en) * | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
UA102709C2 (uk) * | 2008-11-15 | 2013-08-12 | Ріб-Екс Фармасьютікалз, Інк. | Протимікробна композиція |
WO2010096551A2 (en) * | 2009-02-18 | 2010-08-26 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compositions |
GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
WO2012097000A1 (en) * | 2011-01-10 | 2012-07-19 | Pingda Ren | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
BR112013017985B1 (pt) * | 2011-01-14 | 2021-06-29 | Spero Therapeutics Inc. | Formas sólidas de inibidor de girase (r)-1-etil-3-[6-flúor-5-[2-(1-hidróxi-1-metil-etil)pirimidin- 5-il]-7-(tetra-hidrofuran-2-il)-1h-benzimidazol-2-il]ureia, seu sal de ácido clorídrico, método de preparação das mesmas e composição farmacêutica que os compreende |
JP2013034468A (ja) * | 2011-08-10 | 2013-02-21 | Nisshin Sugar Mfg Co Ltd | 発泡成型甘味料 |
WO2013090893A1 (en) * | 2011-12-16 | 2013-06-20 | Celanese Eva Performance Polymers, Inc. | Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermpoplastic polyurethanes |
CN102697751A (zh) * | 2012-05-30 | 2012-10-03 | 河南牧翔动物药业有限公司 | 一种畜禽专用恩诺沙星泡腾分散片及其制备方法 |
-
2015
- 2015-06-18 TW TW108140999A patent/TWI732337B/zh active
- 2015-06-18 TW TW104119676A patent/TWI705814B/zh active
- 2015-06-19 PL PL15810507T patent/PL3157510T3/pl unknown
- 2015-06-19 LT LTEP19165084.5T patent/LT3581180T/lt unknown
- 2015-06-19 ES ES15810507T patent/ES2732865T3/es active Active
- 2015-06-19 HU HUE15810507 patent/HUE044764T2/hu unknown
- 2015-06-19 BR BR112016029761-0A patent/BR112016029761B1/pt active IP Right Grant
- 2015-06-19 CR CR20200565A patent/CR20200565A/es unknown
- 2015-06-19 LT LTEP15810507.2T patent/LT3157510T/lt unknown
- 2015-06-19 CN CN201580044451.8A patent/CN106572982B9/zh active Active
- 2015-06-19 RS RS20211307A patent/RS62538B1/sr unknown
- 2015-06-19 PE PE2016002748A patent/PE20170304A1/es unknown
- 2015-06-19 SI SI201531733T patent/SI3581180T1/sl unknown
- 2015-06-19 CN CN202210565182.1A patent/CN114831955B/zh active Active
- 2015-06-19 AR ARP150101976A patent/AR100920A1/es unknown
- 2015-06-19 HR HRP20211685TT patent/HRP20211685T1/hr unknown
- 2015-06-19 TR TR2019/09417T patent/TR201909417T4/tr unknown
- 2015-06-19 CA CA2952950A patent/CA2952950C/en active Active
- 2015-06-19 AU AU2015276954A patent/AU2015276954B2/en active Active
- 2015-06-19 DK DK15810507.2T patent/DK3157510T3/da active
- 2015-06-19 EA EA201692532A patent/EA034152B1/ru unknown
- 2015-06-19 JP JP2016574040A patent/JP6995479B2/ja active Active
- 2015-06-19 ES ES19165084T patent/ES2897576T3/es active Active
- 2015-06-19 DK DK19165084.5T patent/DK3581180T3/da active
- 2015-06-19 MX MX2016017350A patent/MX368940B/es active IP Right Grant
- 2015-06-19 WO PCT/US2015/036605 patent/WO2015196027A1/en active Application Filing
- 2015-06-19 CR CR20160592A patent/CR20160592A/es unknown
- 2015-06-19 EP EP21188004.2A patent/EP3919057A1/en active Pending
- 2015-06-19 US US14/744,432 patent/US20150366857A1/en not_active Abandoned
- 2015-06-19 HU HUE19165084A patent/HUE056298T2/hu unknown
- 2015-06-19 PL PL19165084T patent/PL3581180T3/pl unknown
- 2015-06-19 PT PT15810507T patent/PT3157510T/pt unknown
- 2015-06-19 PT PT191650845T patent/PT3581180T/pt unknown
- 2015-06-19 RS RS20190773A patent/RS59064B1/sr unknown
- 2015-06-19 SI SI201530783T patent/SI3157510T1/sl unknown
- 2015-06-19 PE PE2021000031A patent/PE20210927A1/es unknown
- 2015-06-19 EP EP19165084.5A patent/EP3581180B1/en active Active
- 2015-06-19 EP EP15810507.2A patent/EP3157510B1/en active Active
- 2015-06-22 UY UY0001036184A patent/UY36184A/es not_active Application Discontinuation
-
2016
- 2016-12-18 IL IL249622A patent/IL249622A0/en unknown
- 2016-12-20 EC ECIEPI201695540A patent/ECSP16095540A/es unknown
- 2016-12-20 PH PH12016502548A patent/PH12016502548A1/en unknown
- 2016-12-20 SV SV2016005349A patent/SV2016005349A/es unknown
- 2016-12-20 CL CL2016003273A patent/CL2016003273A1/es unknown
- 2016-12-20 MX MX2019012608A patent/MX2019012608A/es unknown
-
2019
- 2019-06-21 HR HRP20191133TT patent/HRP20191133T1/hr unknown
- 2019-06-26 CY CY20191100664T patent/CY1121995T1/el unknown
-
2020
- 2020-01-28 US US16/774,709 patent/US20200237744A1/en not_active Abandoned
- 2020-07-15 JP JP2020121083A patent/JP7149991B2/ja active Active
- 2020-10-17 AU AU2020256457A patent/AU2020256457B2/en active Active
- 2020-12-03 CL CL2020003153A patent/CL2020003153A1/es unknown
-
2021
- 2021-11-04 CY CY20211100955T patent/CY1125395T1/el unknown
- 2021-12-14 AU AU2021286284A patent/AU2021286284B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2535666B (en) | Antimicrobial compositions | |
DK3542812T3 (da) | Glycopeptidsammensætninger | |
BR112016023341A2 (pt) | composição desinfetante de ação rápida | |
DK3040326T3 (da) | Haloolefin-baseret sammensætning | |
BR112017001922A2 (pt) | composições fungicidas | |
FR3024363B1 (fr) | Composition thermogelifiable | |
FR3020948B1 (fr) | Composition antimicrobienne | |
DK3451829T3 (da) | Antimikrobielle sammensætninger | |
CL2017000639A1 (es) | Composición | |
BR112016018442A2 (pt) | agentes antibacterianos | |
DK3393254T3 (da) | Sammensætning | |
DK3200827T3 (da) | Sammensætninger | |
BR112017016240A2 (pt) | composição | |
DK3217964T3 (da) | Sammensætning | |
FR3025106B1 (fr) | Composition antimicrobienne | |
FR3019552B1 (fr) | Composition filmogene | |
DK3174396T3 (da) | Synergistisk antimikrobiel sammensætning | |
TR201503831A2 (tr) | Antimipertansif kombinasyon formülasyonları | |
IL249622A0 (en) | Antimicrobial preparations with effervescent substances | |
DK3322295T3 (da) | Sammensætning | |
MA40840A (fr) | Composition herbicide | |
DK3410852T3 (da) | Mikrobicid sammensætning | |
GB2552572B (en) | Antimicrobial compositions | |
UA28385S (uk) | Пластир бактерицидний | |
TH1601002275A (th) | องค์ประกอบสารฆ่าวัชพืช |